STI Clinical Update Webinar– Summer 2024 Update and Review: Syphilis, Chlamydia, and Gonorrhea, County of Lake

Presented by Drs. Kelly Johnson and Kurtis Mohr
Wednesday, July 24, 2024
11:00AM – 1:00PM (PDT)

CME not available for viewing the webinar recording.

""

Learning Objectives

  • Describe the varied clinical manifestations of primary and secondary syphilis in adults and adolescents
  • Appropriately stage and treat syphilis in both pregnant and non-pregnant people
  • Recognize the different sequelae of sexually transmitted C. trachomatis and N. Gonorrhoeae infections & their recommended treatments

How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections 

How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections 

Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with certain sexually transmitted infections (STIs) – including chlamydia (CT), gonorrhea (GC), and trichomoniasis – without the health care provider first examining the partner(s). EPT usually involves patient delivered partner therapy (PDPT), in which the patient delivers the medication or a prescription to their partner(s). While evaluating the partner and providing other needed health services would be ideal, this is often not feasible. EPT can be provided confidentially; it is effective, safe, acceptable to patients and partners, and helps to ensure timely partner treatment.

This resource contains information on how to prescribe EPT in California, including sample prescriptions, information on billing/reimbursement, and patient-facing materials.

For more information on EPT and why it should be prescribed, see “Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers – What is EPT and Why Should I Prescribe It?”

PDF Icon

Examination and Interpretation of Wet Preparations of Vaginal Specimens

Intended for Practicing Clinicians with Prior Wet Mount Experience

The course begins with a fifteen minute didactic presentation on applicable issues of CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. This will be followed by a fifteen minute video that details through the microscope footage of findings on VWM including trichomads, yeast and clue cells associated with BV. The remaining two and one-half hours consists of experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). During this portion of the training, participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.

Learning Objectives

  • Practice proper preparation of saline and KOH specimens of vaginal fluid to increase viability of specimens for microscopic evaluation.
  • Perform proper use of the light microscope to improve examination of saline and KOH wet mount specimens.
  • Assess wet mount microscopy specimens to appropriately interpret findings that support diagnosis of vulvovaginal candidiasis, bacterial vaginosis or trichomoniasis

March 30, 2023 from 2:00PM – 5:00PM (PDT)
UCSF Parnassus Heights Campus: San Francisco, CA
Instructors: Sharon Adler, MD, MPH and Lee Fagen, NP

Syphilis Treatment Intervals in Non-Pregnant Patients: A Clinical Resource for Providers

What are appropriate treatment intervals for late latent syphilis or syphilis of unknown duration in non-pregnant people?

Prepared by the STD Control Branch, California Department of Public Health and California Prevention Training Center. Revised February 2023.

Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers

Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers

Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with treatable sexually transmitted infections (STIs) – including chlamydia, gonorrhea, and trichomoniasis – without the health care provider first examining the partner(s).

This document explains what EPT is and why clinicians in California should prescribe it. In-depth references are also provided.

California Department of Public Health Logo

2021 CDC STI Treatment Guidelines Update: What’s New

December 10, 2021

Presented by Drs. Sharon Adler and Kelly Johnson

Learn more about the 2021 CDC STI Treatment Guidelines. Updated every 4-5 years, CDC’s STI Treatment Guidelines provide current evidence-based diagnostic, management, and treatment recommendations, and serve as a source of clinical guidance for managing sexually transmitted infections (STIs). This webinar will cover 2021 changes.

Learning Objectives

  1. Learn about and become proficient with the treatment updates
  2. Discuss and be able to share the rationale for the updates
  3. Understand the changes needed and apply them to clinical practice

2021 PrEP Clinical Practice Guideline – Clinical Providers’ Supplement

2021 PrEP Clinical Practice Guideline – Clinical Providers’ Supplement

Updated Clinical Providers’ Supplement accompanying the 2021 PrEP Clinical Practice Guideline.

Updates for 2021 include:

  • Checklist updated to include Descovy, 2-1-1 Truvada for MSM, and cabotegravir
  • Added PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) recommendation for HIV prevention in adults 
  • Added information about Descovy and cabotegravir to Patient Information Sheets
CDC logo

2021 PrEP Clinical Practice Guideline

2021 PrEP Clinical Practice Guideline

Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.

Updates for 2021 include:

  • A recommendation to inform all sexually active adults and adolescents about PrEP
  • PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.

Also view the updated PrEP Providers Supplement for 2021.

Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.

Updates for 2021 include:

  • A recommendation to inform all sexually active adults and adolescents about PrEP
  • PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.

Also view the updated PrEP Providers Supplement for 2021.

California STI Treatment Guidelines Table for Adults and Adolescents—2021

California STI Treatment Guidelines Table for Adults and Adolescents—2021

These guidelines reflect the 2021 CDC STI Treatment Guidelines for adults and adolescents who are HIV negative as well as those with HIV.

View the online version of the guidelines

California Department of Public Health Logo

2021 CDC STI Treatment Guidelines Webinar

2021 CDC STI Treatment Guidelines Webinar presented by National Network of STD Prevention Training Center (NNPTC) faculty Dr. Ina Park, Dr. Rosalyn Plotzker, and Dr. Christine Johnston.